Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH–JAPAN study

Gordon, 1989, High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies, Circulation, 79, 8, 10.1161/01.CIR.79.1.8 Goldbourt, 1997, Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men, Arterioscler Thromb Vasc Biol, 17, 107, 10.1161/01.ATV.17.1.107 Kitamura, 1994, High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men, Circulation, 89, 2533, 10.1161/01.CIR.89.6.2533 Hirano, 1997, Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity, Arterioscler Thromb Vasc Biol, 17, 1053, 10.1161/01.ATV.17.6.1053 Moriyama, 1998, A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency, Prev Med, 27, 659, 10.1006/pmed.1998.0340 Curb, 2004, A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly, J Lipid Res, 45, 948, 10.1194/jlr.M300520-JLR200 Barter, 2007, Effects of torcetrapib in patients at high risk for coronary events, N Engl J Med, 357, 2109, 10.1056/NEJMoa0706628 Cannon, 2010, Safety of anacetrapib in patients with or at high risk for coronary heart disease, N Engl J Med, 363, 2406, 10.1056/NEJMoa1009744 Schwartz, 2012, Effects of dalcetrapib in patients with a recent acute coronary syndrome, N Engl J Med, 367, 2089, 10.1056/NEJMoa1206797 Wilkins, 2014, Coronary heart disease risks associated with high levels of HDL cholesterol, J Am Heart Assoc, 3, e000519, 10.1161/JAHA.113.000519 Ko, 2016, High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous cardiovascular conditions: the CANHEART Study, J Am Coll Cardiol, 68, 2073, 10.1016/j.jacc.2016.08.038 Madsen, 2017, Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies, Eur Heart J, 38, 2478, 10.1093/eurheartj/ehx163 Hirata, 2016, The relationship between very high levels of serum high-density lipoprotein cholesterol and cause-specific mortality in a 20-year follow-up study of Japanese general population, J Atheroscler Thromb, 23, 800, 10.5551/jat.33449 Paunio, 1994, HDL cholesterol and mortality in Finnish men with special reference to alcohol intake, Circulation, 90, 2909, 10.1161/01.CIR.90.6.2909 Ueshima, 1982, High-density lipoprotein-cholesterol levels in Japan, JAMA, 247, 1985, 10.1001/jama.1982.03320390047040 Johnson, 1993, Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys, JAMA, 269, 3002, 10.1001/jama.1993.03500230084034 Okamura, 2003, What cause of mortality can we predict by cholesterol screening in the Japanese general population?, J Intern Med, 253, 169, 10.1046/j.1365-2796.2003.01080.x Sekikawa, 2005, Much lower prevalence of coronary calcium detected by electron-beam computed tomography among men aged 40-49 in Japan than in the US, despite a less favorable profile of major risk factors, Int J Epidemiol, 34, 173, 10.1093/ije/dyh285 Murakami, 2008, Relation of blood pressure and all-cause mortality in 180,000 Japanese participants: pooled analysis of 13 cohort studies, Hypertension, 51, 1483, 10.1161/HYPERTENSIONAHA.107.102459 Asayama, 2014, Cardiovascular risk with and without antihypertensive drug treatment in the Japanese general population: participant-level meta-analysis, Hypertension, 63, 1189, 10.1161/HYPERTENSIONAHA.113.03206 Nakamura, 2015, Smoking increases the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease, Kidney Int, 88, 1144, 10.1038/ki.2015.212 Satoh, 2015, Combined effect of blood pressure and total cholesterol levels on long-term risks of subtypes of cardiovascular death: evidence for cardiovascular prevention from observational cohorts in Japan, Hypertension, 65, 517, 10.1161/HYPERTENSIONAHA.114.04639 Hirata, 2017, A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan, Eur J Epidemiol, 32, 547, 10.1007/s10654-016-0203-1 Srinivasan, 1975, Studies on the interaction of heparin with serum lipoproteins in the presence of Ca2+, Mg2+, and Mn2+, Arch Biochem Biophys, 170, 334, 10.1016/0003-9861(75)90125-3 Wiebe, 1985, Six methods for isolating high-density lipoprotein compared, with use of the reference method for quantifying cholesterol in serum, Clin Chem, 31, 746, 10.1093/clinchem/31.5.746 Sugiuchi, 1995, Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin, Clin Chem, 41, 717, 10.1093/clinchem/41.5.717 Mannami, 1997, Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study, Stroke, 28, 518, 10.1161/01.STR.28.3.518 Arima, 2003, Validity of the JNC VI recommendations for the management of hypertension in a general population of Japanese elderly: the Hisayama study, Arch Intern Med, 163, 361, 10.1001/archinte.163.3.361 Ohkubo, 2005, Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study, J Am Coll Cardiol, 46, 508, 10.1016/j.jacc.2005.03.070 Kuriyama, 2006, Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study, JAMA, 296, 1255, 10.1001/jama.296.10.1255 Bowman, 2017, Effects of anacetrapib in patients with atherosclerotic vascular disease, N Engl J Med, 377, 1217, 10.1056/NEJMoa1706444 Boden, 2011, Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy, N Engl J Med, 365, 2255, 10.1056/NEJMoa1107579 Rader, 2009, The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis, J Lipid Res, 50 Suppl, S189, 10.1194/jlr.R800088-JLR200 Nissen, 2007, Effect of torcetrapib on the progression of coronary atherosclerosis, N Engl J Med, 356, 1304, 10.1056/NEJMoa070635 Ronsein, 2016, Niacin therapy increases high-density lipoprotein particles and total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subject, Arterioscler Thromb Vasc Biol, 36, 404, 10.1161/ATVBAHA.115.306268 Nicholls, 2015, Cholesterol efflux capacity and pre-beta-1 HDL concentrations are increased in dyslipidemic patients treated with evacetrapib, J Am Coll Cardiol, 66, 2201, 10.1016/j.jacc.2015.09.013 Khera, 2011, Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis, N Engl J Med, 364, 127, 10.1056/NEJMoa1001689 Rohatgi, 2014, HDL cholesterol efflux capacity and incident cardiovascular events, N Engl J Med, 371, 2383, 10.1056/NEJMoa1409065 Ueshima, 2007, Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke, J Atheroscler Thromb, 14, 278, 10.5551/jat.E529 van Tol, 1998, Changes in postprandial lipoproteins of low and high density caused by moderate alcohol consumption with dinner, Atherosclerosis, 141 Suppl 1, S101, 10.1016/S0021-9150(98)00226-3 van der Gaag, 2001, Alcohol consumption stimulates early steps in reverse cholesterol transport, J Lipid Res, 42, 2077, 10.1016/S0022-2275(20)31537-6 Hirano, 1992, Polydisperse low-density lipoproteins in hyperalphalipoproteinemic chronic alcohol drinkers in association with marked reduction of cholesteryl ester transfer protein activity, Metabolism, 41, 1313, 10.1016/0026-0495(92)90101-F Wang, 2011, Inverse association of plasma level of high-density lipoprotein cholesterol with intracerebral hemorrhage, J Lipid Res, 52, 1747, 10.1194/jlr.P008755 Tirschwell, 2004, Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups, Neurology, 63, 1868, 10.1212/01.WNL.0000144282.42222.DA Ueshima, 1980, Multivariate analysis of risk factors for stroke. Eight-year follow-up study of farming villages in Akita, Japan, Prev Med, 9, 722, 10.1016/0091-7435(80)90017-1 Wang, 2013, Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis, Stroke, 44, 1833, 10.1161/STROKEAHA.113.001326 Sturgeon, 2007, Risk factors for intracerebral hemorrhage in a pooled prospective study, Stroke, 38, 2718, 10.1161/STROKEAHA.107.487090